Avalo Therapeutics, Inc.
$928.87M- Market cap
- $1.03B
- Debt
- +-$5.17M
- Cash
- −$98.34M
Capital structure 101% equity / -1% debt · EV / Revenue 15743.53x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AVTX · current priceP/S 17497.92x
$19.25Latest market snapshot
Implied fair value · at NWN's multiple
$0.00100.0% below market
0.00 AVTX revenue / share×1.61x NWN P/S=$0.00
Market $19.25Implied $0.00
NWN · current priceP/S 1.61x
$49.20Latest market snapshot
Implied fair value · at AVTX's multiple
$535,977.061,089,284.3% above market
30.63 NWN revenue / share×17497.92x AVTX P/S=$535,977.06
Market $49.20Implied $535,977.06